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Abstract
Background: TFEB (transcription factor EB) regulates metabolic homeostasis through its activation of lysosomal
biogenesis following its nuclear translocation. TFEB activity is inhibited by mTOR phosphorylation, which signals its
cytoplasmic retention. To date, the temporal relationship between alterations to mTOR activity states and changes
in TFEB subcellular localization and concentration has not been sufficiently addressed.
Methods: mTOR was activated by renewed addition of fully-supplemented medium, or inhibited by Torin1 or nutrient
deprivation. Single-cell TFEB protein levels and subcellular localization in HeLa and MCF7 cells were measured over a
time course of 15 hours by multispectral imaging cytometry. To extract single-cell level information on heterogeneous
TFEB activity phenotypes, we developed a framework for identification of TFEB activity subpopulations. Through
unsupervised clustering, cells were classified according to their TFEB nuclear concentration, which corresponded
with downstream lysosomal responses.
Results: Bulk population results revealed that mTOR negatively regulates TFEB protein levels, concomitantly to
the regulation of TFEB localization. Subpopulation analysis revealed maximal sensitivity of HeLa cells to mTOR
activity stimulation, leading to inactivation of 100 % of the cell population within 0.5 hours, which contrasted
with a lower sensitivity in MCF7 cells. Conversely, mTOR inhibition increased the fully active subpopulation only
fractionally, and full activation of 100 % of the population required co-inhibition of mTOR and the proteasome.
Importantly, mTOR inhibition activated TFEB for a limited duration of 1.5 hours, and thereafter the cell population
was progressively re-inactivated, with distinct kinetics for Torin1 and nutrient deprivation treatments.
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Conclusion: TFEB protein levels and subcellular localization are under control of a short-term rheostat, which is
highly responsive to negative regulation by mTOR, but under conditions of mTOR inhibition, restricts TFEB
activation in a manner dependent on the proteasome. We further identify a long-term, mTOR-independent
homeostatic control negatively regulating TFEB upon prolonged mTOR inhibition. These findings are of relevance
for developing strategies to target TFEB activity in disease treatment. Moreover, our quantitative approach to
decipher phenotype heterogeneity in imaging datasets is of general interest, as shifts between subpopulations
provide a quantitative description of single cell behaviour, indicating novel regulatory behaviors and revealing
differences between cell types.
Keywords: Transcription Factor EB (TFEB), Mammalian target of rapamycin (mTOR), Autophagy, Lysosomes,
Proteasome, Systems biology, Subpopulation dynamics, Single cell, Multispectral imaging cytometry
Background
Autophagy, a process of lysosomal degradation essential
for cellular homeostasis, is transcriptionally regulated by
Transcription Factor EB (TFEB) [1–3], which coordinates
the expression of genes involved in lysosome biogenesis,
autophagy and endocytosis [1, 2, 4]. Under normal growth
conditions TFEB is transiently recruited to the lysosomes
through its interaction with active RAG GTPases at
the lysosomal membrane [5]. Active RAG GTPases also
recruit the anabolic kinase complex mTOR, which phos-
phorylates TFEB at serine S211 to promote its dissociation
from the lysosome and binding with 14-3-3 protein family
members, which retain TFEB in the cytoplasm and inhibit
its transcriptional activity [5–7]. Upon amino acid starva-
tion, RAG GTPases are inactivated [8] resulting in the loss
of lysosomal recruitment of TFEB and mTOR. Conse-
quently, the cytoplasmic pool of TFEB becomes dephos-
phorylated, leading to the dissociation from 14-3-3
proteins and ultimately to nuclear accumulation of TFEB.
Besides amino acid starvation, pharmacological inhibition
of mTOR and lysosomal stresses result in TFEB de-
phosphorylation and nuclear accumulation [7, 9]. In
the nucleus, TFEB activates the transcription of the CLEAR
network (Coordinated Lysosomal Expression and Regula-
tion), which is composed of at least 471 direct targets, in-
cluding a battery of lysosomal and autophagy genes [1].
Abnormalities in autophagic processes can lead to
neurodegenerative diseases and cancer [10]. Moreover,
recent studies have identified TFEB and other family
members as key players for metabolic reprogramming
in pancreatic cancer [11, 12]. Thus, TFEB presents an
attractive target for manipulating the cellular autopha-
gic capacity in disease treatment. To date, studies on
TFEB have primarily focused on the role of mTOR-
mediated regulation of nuclear-cytoplasmic TFEB shut-
tling. Intriguingly, transcription of TFEB-controlled
autophagosomal and lysosomal genes is increased in
cells overexpressing TFEB [1, 2, 6] and overall cellular
TFEB protein levels are reduced following TFEB activa-
tion via long-term (15 hours) chloroquine-induced
lysosomal stress [7], suggesting TFEB concentration
changes may contribute to the regulation of TFEB sig-
naling. However, the relationship between mTOR ac-
tivity states and temporal changes in TFEB subcellular
localization and concentration has not been elucidated.
To that end, we performed time course analysis over
15 hours of TFEB levels and localization by quantita-
tive Western blotting and imaging cytometry. We acti-
vated mTOR by fresh addition of fully-supplemented
medium (FM), or inhibited mTOR by Torin1 treat-
ment [13] or nutrient deprivation [14]. We report that
overall cellular TFEB levels transiently decrease in re-
sponse to small increases in mTOR activation, and
transiently increase in response to mTOR inhibition.
Both Western blot and population-averaged imaging
results displayed high variability, suggesting that het-
erogeneous TFEB responses within the cell population
may cache important information on these complex
dynamics. We therefore analyzed single-cell imaging
cytometry data using spanning-tree progression analysis
of density-normalized events (SPADE) agglomerative clus-
tering [15], as a basis for unbiased and quantitative detec-
tion of spatial and temporal dynamics of subpopulations.
Using unsupervised clustering, we identified three TFEB
phenotype subpopulations, with low, medium and high
nuclear TFEB concentrations. We found that total cel-
lular TFEB levels and subcellular localization are dir-
ectly under control of a short-term rheostat controlled
by mTOR. mTOR inhibition rapidly activates TFEB in a
fraction of cells, for a limited duration, with distinct
TFEB subpopulation re-inactivation dynamics in response
to Torin1 vs. nutrient deprivation. Moreover, time course
subpopulation analysis identified a correlation between
TFEB protein levels and nuclear localization, and revealed
differences between HeLa and MCF7 cells in the sensi-
tivity of TFEB to mTOR regulation. Finally, subpopula-
tion analysis revealed that in response to mTOR
inhibition, maximal nuclear localization of TFEB is ne-
gatively regulated by the proteasome, independently of
TFEB concentration.
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Methods
Materials
Cell culture reagents were obtained from Invitrogen,
Sigma, Lonza and PAN Biotech. Methanol-free parafor-
maldehyde was obtained from Alfa Aesar. Torin1 was pur-
chased from Merck, DMSO from Genaxxon Biosciences
and U0126 was from Biovision. Hoechst 33342 was pur-
chased from ImmunoChemistry.
Cell culture and treatments
The human cervical cancer cell line HeLa Kyoto and the
human breast cancer cell line MCF7 (obtained from CLS
Cell lines service, Heidelberg) were cultured in DMEM
(1 g/L D-glucose, 0.11 g/L sodium pyruvate), supplemented
with 2 mM L-Glutamine, 10 % Fetal Bovine Serum,
non-essential amino acids and penicillin/streptomycin/
amphotericin B. Cells were routinely tested for myco-
plasma contamination using Hoechst 33342. Transient
transfections were performed using jetPRIME (Polyplus)
according to the manufacturer’s instructions. Transfection
complexes were removed after 6 hours and experiments
performed at 24 hours of expression. Nutrient deprivation
(ND) was introduced using glucose-containing HBSS (Life
Technologies; no. 14025), supplemented with penicillin/
streptomycin/amphotericin B. For drug treatments, cells
were incubated in FM or HBSS, containing one or a com-
bination of the following reagents: Torin1 (2 μM), U0126
(10 μM), epoxomicin (1 μM), and actinomycin D (1 μg/ml).
Co-treatments with epoxomicin, actinomycin D or DMSO
included a pre-treatment period (Fig. 7c-e). Cells were
pretreated with Epox, ActD or vehicle control (DMSO)
for 1 hour, and subsequently treated with FM supple-
mented with Torin1 in combination with the respective
pretreatment reagent for 1 hour. For pre-treatments the
drugs were directly added to the culture medium, without
addition of fresh FM.
Cloning
Entry Clones were obtained from the German cDNA
Consortium of the German Cancer Research Center.
N-terminally tagRFP-tagged clone of 14-3-3 protein
isoform YWHAG, RFP-YWHAG, was generated using
the Gateway Cloning System (Life Technologies). TFEB
wild type was cloned using forward primer: 5′-gtaAAGC
TTcgatggcgtcacgcatagggttgcgcatg-3′ and reverse primer
5′- tacGGTACCttacagcacatcgccctcctccat-3′ and inserted
into pEGFP (Invitrogen) generating TFEB with N-
terminal GFP fusion, GFP-TFEB.
Immunofluorescence and fluorescence microscopy
Fifty thousand cells were plated per well of an 8 well μ-
slide microscopy chamber (ibidi) 24 hours before treat-
ment. Following drug treatments, cells were fixed with 4 %
paraformaldehyde in PBS for 15 minutes, permeabilized
with 0.3 % Triton X-100 in PBS for 10 minutes and
blocked with 3 % BSA in 0.3 % Triton X-100/PBS for
1 hour. Cells were then incubated with primary antibodies
against LAMP1 (Hybridoma Bank; #H4A3-s), TFEB (Cell
Signaling; #4240S), or p-4E-BP1 (Cell Signaling; #2855S) in
0.3 % Triton X-100/PBS at 4 °C overnight. Fluorescence
staining was performed using anti-rabbit Alexa Fluor 488
or 594 secondary antibodies (Life Technologies; #A11008,
#A11012) in 0.3 % Triton X-100/PBS at room temperature
for 1 hour. Fluorescence microscopy was performed with a
DeltaVision microscope system (Applied Precision) using a
60x oil immersion objective (Olympus) and a digital CCD
camera (Hamamatsu Photonics). Following acquisition, im-
ages were deconvolved with Softworks V3.5.1 (Applied
Precision) to increase spatial resolution. Images were
prepared using ImageJ (rsbweb.nih.gov/ij/). Representative
images shown are total intensity projections (Z-axis scans).
Immunoblotting
Six hundred thousand cells/well were plated in 6-well
plates, 24 hours prior drug treatment. Following drug
treatments whole cell lysates were prepared of adherent
and floating cells with RIPA lysis buffer containing 1X
EDTA-free protease inhibitor cocktail (Roche) and 2X
PhosphoSTOP (Roche). Dosed protein samples were
separated on pre-cast 4–12 % Bis-Tris gels (Invitrogen)
and transferred to nitrocellulose using the iBlot dry blot-
ting system (Invitrogen). Blocked membranes were incu-
bated with primary antibodies against TFEB (#101532;
Santa Cruz), LAMP1 (# H4A3-s; Hybridoma Bank), LC3
(#2775; Cell Signaling), 4E-BP1 (#9452; Cell Signaling),
phospho-4E-BP1 (#9459S; Cell Signaling), p70-S6K1
rabbit IgG (#9202S; Cell Signaling), phospho-p70-S6K1
(#9205S; Cell Signaling) and GAPDH (#25778; Santa Cruz).
HRP-conjugated anti-rabbit IgG (#213110-01; GeneTex)
and anti-mouse IgG (#213111-01; GeneTex) antibodies
were used as secondary antibodies. For immunodetection
membranes were incubated with peroxide and luminol so-
lution (1:1) and analyzed with a chemiluminescence imager
(Intas). Protein bands were quantified using the gel analysis
tool of ImageJ and normalized to the loading control
GAPDH. Blots shown are representative of at least three in-
dependent experiments.
Multispectral imaging cytometry
Flow cytometry coupled to high resolution imaging was
performed using the ImageStreamX cytometer operated
with INSPIRE 4.1.501.0 software (Amnis), using a 40X
air objective.
Data collection
Two hundred fifty thousand cells per well of a 12-well
plate were plated on the day before drug treatments. Fol-
lowing drug treatments, cells were trypsinized, harvested
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by centrifugation at 800 g for 5 minutes at 4 °C and fixed
with 4 % paraformaldehyde for 15 minutes at room
temperature. For detection of endogenous TFEB, cells
were immunostained as stated above. Nuclei were labeled
with 1 μg/mL Hoechst 33342 in PBS for 10 minutes.
Compensation controls were generated from single-color
control cells. Endogenous TFEB was immunostained with
an antibody against TFEB and Alexa Fluor 594. Lysosomes
were immunostained with an antibody against LAMP1
and Alexa Fluor 647. For measurements cells were resus-
pended in PBS. Fluorescence signal of Hoechst 33342 was
excited using the 405 nm laser and detected in channel 1
(420–480 nm). Alexa Fluor 594 was excited using the
561 nm laser and the fluorescence signal was detected in
channel 4 (595–642 nm).
Data processing
All data processing was performed using the IDEAS v6.0
software (Amnis). For each treatment and time point a
total of 10000 cells were collected. Following compensa-
tion, cells were gated as single (based on the area and as-
pect ratio of the bright filed mask) and in-focus (based
on the Gradient RMS of the bright filed image). With
the exception of 15 hours, at least 2000 cells were ana-
lyzed after gating. The nuclear, cytoplasmic and cellular
masks of gated cells were calculated based on the follow-
ing morphological and logical operations: Cell, default
mask for TFEB channel OR 5-pixel erosion of default
bright field mask; Nucleus, 70 % Threshold mask on
Hoechst channel; Cytoplasm: Cell AND NOT Nucleus.
The features “Intensity Cell, Nucleus and Cytoplasm”
were calculated as the total intensities (background
subtracted) in their respective masks. The features “Con-
centration Cell, Nucleus and Cytoplasm” were calculated
by dividing the intensity features by the area of their re-
spective masks (in μm2). The feature “Nuclear percent-
age” was calculated as the ratio between the features
“Intensity Nucleus” and “Intensity Cell”, multiplied by
100. The feature “Max Contour Position” was calculated
with a build in function available in IDEAS software
[16]. The feature “Mean Pixel Nu/Cyto” was calculated
based on masks which underestimated the nuclear and
cytoplasmic compartments in order to avoid including
cytoplasmic pixels in the nuclear signal or including
background or nuclear pixels in the cytoplasmic signal.
Underestimated masks were obtained by morphological
erosion of the original masks. These feature values were
exported to.fcs-files for further processing with the clus-
tering software SPADE V2.0 (Spanning-tree Progression
Analysis of Density-normalized Events) [15]. The num-
ber of clusters and combination of input features was
optimized as presented on the Results Section. The
remaining SPADE input parameters were set to default
values (arcsinh with cofactor = 5, neighborhood size = 5,
local density approximation factor = 1.5, max allowable
cells in pooled down-sampled data = 50000, fixed num-
ber of cells remained = 20000, Algorithm: K-means).
Clustering results were exported to.fcs files and subse-
quently converted to .txt files using the IDEAS software.
Text files were imported into MATLAB R2014a for data
representation and further analysis.
Data representation
Mean population responses were obtained by averaging
the single-cell data from a specific treatment, time
point and repetition. All subpopulations were identified
according to the classification model obtained from
FM and Torin1 data in Fig. 4 (Refer to Additional file 1:
Figure S1 for further explanation of the classification
work flow).
Statistical comparisons
Statistical comparisons were performed with Student’s
two-tailed t-test or the non-parametric test Wilcoxon-
rank-sum (two-sided). The latter was used in inter-cluster
comparisons of non-normally distributed variables, in-
cluding the features “Mean Pixel Nuc/Cyto” (Figs. 4b, d
and 5b) and the discrete variable “LAMP1 Max Contour
Position” (Fig. 6d).
Results
Regulation of TFEB localization and protein levels
by mTOR
We first established conditions for suppressing mTOR
activity with the specific inhibitor Torin1 [13], and in-
creasing mTOR activity by the renewed addition of
fully-supplemented medium (FM) (illustrated in Fig. 1a).
Torin1-mediated TFEB activation has been reported for
concentrations ranging from 0.25 μM [5, 6, 9] to 2 μM
[7]. Thus, we treated HeLa cells with 0.25 to 2 μM
Torin1 for 1.5 and 3.0 hours, and determined the phos-
phorylation state of the mTOR substrates 4E-BP1 and
p70-S6K1 by Western blot. Maximal inhibition of 4E-
BP1 and p70-S6K1 phosphorylation was achieved in
response to 2 μM after 3 hour treatment (Fig. 1b, c).
High-resolution imaging further demonstrated that at
3 hours of treatment with 2 μM Torin1, immunofluores-
cence detection of phosphorylated 4E-BP1 was fully sup-
pressed, and nuclear accumulation of TFEB was potently
induced (Fig. 1d). Interestingly, total cellular TFEB im-
munofluorescence appeared strongly increased under
Torin1 treatment, suggesting that mTOR inhibition in-
creased TFEB protein levels. Of note, the addition of fresh
FM resulted in an increased immunofluorescence signal
of phosphorylated 4E-BP1, indicating mTOR activation by
the replenished metabolic substrates and growth factors
present in fresh FM. Consistent with increased mTOR
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activity, TFEB was predominantly retained in the cyto-
plasm under fresh FM conditions.
Time course quantification of TFEB response to
modulations in mTOR activity by Western blot analysis
To quantitatively investigate the effect of mTOR activity
modulation on TFEB protein levels we treated HeLa
cells with either fresh FM alone or containing 2 μM
Torin1 over a time course of 15 hours, and measured
levels of TFEB and phosphorylated 4E-BP1 by quantita-
tive Western blot. Following the addition of fresh FM,
TFEB protein levels were significantly decreased between
0.5, 1 and 3 hours, followed by a prolonged recovery to
basal levels (Fig. 2a, b). In parallel, 4E-BP1 phosphoryl-
ation was stable in the first hour and then decreased
over time, significantly at 5 and 15 hours (Fig. 2a, c).
Notably, in contrast to imaging results (Fig. 1d), a sig-
nificant increase in 4E-BP1 phosphorylation at 3 hours
was not detected after addition of FM (Fig. 2c), indicat-
ing that in response to the addition of fresh FM mTOR
is only mildly up-regulated, at levels below the sensitivity
of Western blot analysis. However, at time points of 5
and 15 hours the reduction to 4E-BP1 phosphorylation
suggests a progressive and significant reduction to
mTOR activity.
Torin1 (2 μM) treatment on the other hand initially re-
sulted in stable TFEB protein levels, which increased sig-
nificantly after 3 hours (Fig. 2d, e), similar to as observed
by imaging (Fig. 1d). Similar to following long-term
(15 hour) mTOR inhibition with chloroquine [7], follow-
ing 5 and 15 hours of Torin1 treatment TFEB levels were
reduced (Fig. 2d, e), albeit with a high degree of variation
between experiments. Importantly, Torin1 inhibition of
4E-BP1 phosphorylation was maintained also at 15 hours
(Fig. 2f). These findings suggest that total TFEB levels are
oppositely regulated by Torin1 and FM treatments during
the initial 3-hour treatment period, followed by a pro-
longed TFEB recovery to initial levels. However, for most
time points, the variability of immunoblotting data was
too high to infer dynamic behavior of TFEB.
Fig. 1 Characterization of the effect of Torin1 and fresh nutrients on mTOR and endogenous TFEB. a Schematic representation of the effects of
Torin1 and fresh fully-supplemented medium (FM) on the regulation of TFEB by mTOR. b Dose-response of the effect of Torin1 on mTOR activity.
HeLa cells were treated with FM containing the indicated concentrations of Torin1, or kept in culture medium (non-treated, NT), for 1.5 or 3 hours,
and phosphorylation of the mTOR substrates 4E-BP1 and p70-S6K1 was measured by Western blotting. c Quantification of the ratio of phosphorylated
4E-BP1 (p-4E-BP1) to total 4E-BP1. Graphs display mean values of three independent experiments normalized to NT values. Error bars denote mean ±
SD of three independent experiments. Statistical significance was tested vs. NT conditions (Student’s two-tailed t-test; **, p ≤ 0.01; ***, p ≤ 0.001).
d Immunofluorescence of TFEB and p-4E-BP1, as a read-out for mTOR activity, in response to FM and Torin1. HeLa cells were kept in culture
medium (non-treated, NT), treated with fresh FM, or with FM supplemented with Torin1 (2 μM) for 3 hours and immunostained for TFEB and p-4E-BP1.
To reveal varying intensity levels the look-up-table ‘Fire’ (ImageJ) was applied to grey scale images, representing intensity values ranging from low
(dark purple) to high (white) as displayed in color scale bar. Scale bars, 20 μm
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Mean population time course quantification of TFEB
response to modulations in mTOR activity by multispectral
imaging cytometry
Multispectral imaging cytometry for quantification of
endogenous TFEB in cell populations
TFEB exerts its activity in the nucleus, and thus spatial
dynamics of TFEB signaling contain relevant informa-
tion. We therefore performed single-cell analysis of
TFEB subcellular localization and protein levels in cell
populations using the imaging cytometer, ImageStreamX
(ISX) [17]. For each obtained single-cell image, the nu-
clear and cytoplasmic compartments were segmented,
and based on these masks and the total fluorescence
intensity of endogenous TFEB, two normalized features
were calculated to report spatial concentration states.
The first feature, “Mean Pixel Nuc/Cyto”, reflects the
nuclear/cytoplasmic ratio of TFEB concentration, and
was calculated as the ratio of the mean pixels from
each compartment. The second feature, referred to as
“Concentration”, was determined by normalizing the
total intensity of TFEB to the cell area (described in
Methods).
To gauge the sensitivity of imaging cytometry (ISX)
for assessing TFEB subcellular localization we compared
the nuclear/cytoplasmic ratios of TFEB (Fig. 3a), and
TFEB and Hoechst intensity profiles (Additional file 2:
Figure S2), between ISX and high-resolution wide field
imaging (WF) data-sets. Extended sets of representative
ISX images for each condition are presented in Additional
file 3: Figure S3. Similar intensity profiles were obtained
with both techniques for all conditions. Furthermore, the
nuclear/cytoplasmic ratios obtained for WF were higher
than for ISX measurements. However, qualitatively
similar FM and Torin1 responses were obtained. Both
imaging approaches reported reduced nuclear localization
in response to 3 hour FM treatment (8 % reduction
for WF and 19 % for ISX) and increased nuclear
localization upon treatment with Torin1 (38 % in-
crease for WF and 47 % for ISX). We thus conclude
that the ISX approach is more sensitive. Moreover,
higher population sampling permits more robust
quantitative analysis of relative changes induced by
conditions, and, importantly, allows for improved
significance testing.
Fig. 2 Quantitative Western blot analysis of TFEB protein levels in response to mTOR activity modulations. a HeLa cells were treated with fresh
FM to enhance mTOR activity. At the indicated time points, levels of TFEB and phosphorylated 4E-BP1 (p-4E-BP1) were analyzed by Western
blotting. Lanes for time point ‘0’ originate from same membrane as later time points. b Quantified values for TFEB, normalized to loading control
GAPDH, shown relative to time point ‘0’. c Quantified values for p-4E-BP1, normalized to total 4E-BP1, shown relative to time point ‘0’. d HeLa cells
were treated with FM containing 2 μM Torin1. At the indicated time points, levels of TFEB and phosphorylated 4E-BP1 (p-4E-BP1) were analyzed
by Western blotting. e Quantified values for TFEB, normalized to loading control GAPDH, shown relative to time point ‘0’. f Quantified values for
p-4E-BP1, normalized to total 4E-BP1, shown relative to time point ‘0’. Error bars denote mean ± SD of three independent experiments. Statistical
significances were tested vs. time point ‘0’ (Student’s two-tailed t-test; *, p ≤ 0.05; ***, p ≤ 0.001)
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Fig. 3 (See legend on next page.)
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Time course quantification of mean TFEB responses to FM
and Torin1 treatments
Next, we assessed the mean population responses in
HeLa cells treated under the conditions and time points
reported in Fig. 2. Initially (t = 0), TFEB displayed a
slightly higher concentration in the nuclear compart-
ment, with a nuclear/cytoplasmic ratio of 1.4 (Fig. 3b).
Upon treatment with fresh FM, at 0.5 hours the nuclear/
cytoplasmic ratio rapidly decreased (from 1.4 to 1.0),
and then gradually increased back to initial levels during
the later time points. Consistent with Western blot find-
ings, fresh FM induced a rapid, 14 % decrease in mean
total cell TFEB concentrations within 0.5 hours, which
was maintained up to 15 hours (Fig. 3c).
Upon treatment with Torin1, at 0.5 hours the nuclear/
cytoplasmic ratio increased (from 1.4 to 1.9), peaking at
1 hour, and following 1.5 hours was gradually reduced to
a final distribution of 1.4 at 15 hours, similar to time
point 0 (Fig. 3b). Consistent with Western blot findings,
Torin1 increased cellular TFEB concentration (Fig. 3c),
significantly at 1.5 (45 %) and 3 hours (38 %), after
which concentrations were reduced to approximately
initial (t = 0) levels.
We further evaluated the effect of fresh FM and
Torin1 treatments in MCF7 cells. Consistent with the
findings in HeLa cells, within 1 hour of treatment with
fresh FM the TFEB nuclear/cytoplasmic ratio slightly but
non-significantly decreased from 1.8 to 1.7 (Fig. 3d) and
overall TFEB protein levels were reduced by 5 % (Fig. 3e).
Conversely, Torin1 treatment increased the nuclear/
cytoplasmic ratio to 2.2 (Fig. 3d) and increased TFEB
levels by 20 % (Fig. 3e). As in HeLa cells, TFEB nuclear
localization and cellular concentration increased transi-
ently in response to Torin1 and, after approximately
1 hour, decreased gradually. Of note, in MCF7 cells,
at 15 hours of Torin1 treatment TFEB concentration
decreased below the initial values.
Taken together, ISX-based analysis of mean population
responses support Western blot findings, wherein
mTOR inhibition by Torin1 increases TFEB protein
levels in HeLa (Figs. 2e and 3c) as well as in MCF7 cells
(Fig. 3e). Conversely, addition of fresh FM, to mildly in-
crease mTOR activity (Fig. 1d), led to a slight, but sig-
nificant, reduction in TFEB levels (Figs. 2b and 3c, e).
Furthermore, these results indicate that changes in TFEB
protein levels correlate with significant shifts of TFEB
between nuclear and cytoplasmic compartments.
Agglomerative clustering analysis of single cell
multispectral imaging cytometry data identifies
underlying subpopulation dynamics and elucidates
temporal TFEB regulation
As Western blot and population-averaged ISX analyses
report bulk population dynamics of TFEB, we hypothe-
sized that cell-to-cell heterogeneity in TFEB signaling
may contribute to time point variability for both ap-
proaches, and thereby contain relevant information on
TFEB dynamics. Therefore, we sought to quantify subpop-
ulation TFEB responses from single cell multispectral im-
aging cytometry data using SPADE-based agglomerative
clustering [15].
Analytical framework for subpopulation analysis of TFEB
distribution in time course datasets
Our framework for subpopulation identification consists
of five main steps: (I) feature extraction, (II) data merge,
(III) clustering, (IV) phenotypes assessment, and (V)
time course distribution analysis (Fig. 4a). In the first
step, multiple quantitative features, including subcellular
localization and total protein levels, are calculated for
each cell from all treatments and time points. In the sec-
ond step, the extracted features from all conditions are
merged together, to ensure that clustering is not influ-
enced by time points and treatments, and thus is un-
biased. In the third step, the clustering algorithm SPADE
is used to split the cells into a given number of groups
(clusters), which should represent different phenotypes.
In the fourth step, the clustering outcome is evaluated
based on several criteria to assess its biological soundness,
and the clustering step is iteratively repeated to establish a
combination of features and cluster number (if clusters
exist) for which the results satisfy all evaluation criteria.
Finally, in the fifth step, we trace back the dynamic
distribution of the population among the obtained
clusters. Specifically, for each treatment and time
point, we determine the percentage of cells belonging
to each cluster. Assuming that the clusters represent
biologically-meaningful phenotypes, the redistribution
(See figure on previous page.)
Fig. 3 Multispectral imaging cytometry quantification of TFEB localization and levels in response to mTOR activity modulations. Cells were kept in
culture medium (NT, non-treated), or treated with fresh FM or FM supplemented with Torin1 (2 μM). Following, cells were immunostained for
TFEB and nuclei labelled with Hoechst 33342. a Representative fluorescence images and quantified TFEB nuclear localization in HeLa cells at 3 hours of
treatment, measured with high-resolution wide field imaging (WF, left panels) or with the multispectral imaging cytometer ImageStreamX (ISX, right
panels). Graphed values represent the mean ± SD nuclear/cytoplasmic ratio of 25 to 30 randomly selected cells of one representative experiment from
three independent repetitions. Statistical significances were tested vs. NT control (Student’s two-tailed t-test; ***, p ≤ 0.001; n.s., p > 0.05). b-e Time
course of mean population response of TFEB subcellular localization and protein levels for treatments with Torin1 or fresh FM, in HeLa and MCF7 cell
lines. Concentrations are shown relative to time point ‘0’. Reported values represent the mean among three independent experiments ± SD. Statistical
significances were tested vs. time point ‘0’, which corresponds to the NT control (Student’s two-tailed t-test; *, p ≤ 0.05; **, p ≤ 0.01)
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Fig. 4 (See legend on next page.)
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of cells among the different clusters should then indi-
cate the development of subpopulations.
For this analysis to be valid, we utilize the dynamics
of the subpopulation response to evaluate the consistency,
i.e. biological soundness, of the clustering results (step IV)
based on the following criteria:
– Criterion 1: The temporal evolution of the
percentage of cells in each cluster should be
consistent among repetitions, to assure the
reproducibility of subpopulation dynamics.
(See Additional file 4: Figure S4 and Additional
file 5: Figure S5a).
– Criterion 2: The distribution of cells in each cluster
should follow independent dynamics. We assume
that if the distribution of cells in two or more
clusters are affected in the same way by the
treatments, this would indicate that the clusters are
redundant (See Additional file 5: Figure S5b).
Identification of three TFEB activation phenotypes/
subpopulations
We applied this framework to identify subpopulations in
the response to FM and Torin1 treatments. The features
used for this analysis included the nuclear/cytoplasmic
ratio, and areas, concentrations and total intensities in
the segmented compartments (cellular, nuclear and cyto-
plasmic masks).
After evaluating different feature combinations and num-
ber of clusters, we determined that our evaluation criteria
were satisfied by the single feature “Mean Pixel Nuc/Cyto”,
i.e. nuclear/cytoplasmic ratios, and a total of three, statisti-
cally different clusters. Based on the nuclear/cytoplasmic
ratios, the three clusters were classified as “Inactive”, mod-
erately active (denoted as “Medium”), and “Active”. The
“Active” cluster has the highest nuclear localization and the
“Inactive” cluster has the lowest nuclear localization, i.e.
highest cytoplasmic retention (Fig. 4b).
We characterized the predicted clusters based on the
frequency distribution and mean values of a subset of
features that were not included in the cluster generation.
TFEB nuclear percentage and cellular concentration
features (described in Methods) yielded normal distribu-
tions within predicted clusters, with statistically-different
means (Fig. 4c), further indicating that the predicted clus-
ters represent biologically-meaningful subpopulations.
Interestingly, the “Active” cluster contained the highest
total cellular TFEB concentration. We confirmed this
positive correlation between TFEB nuclear localization
and TFEB protein levels through statistical analysis,
with a correlation coefficient of 0.53 (See Additional file 1:
Figure S1, panel II). To test whether TFEB protein levels
and localization were correlated independently of
mTOR, we increased cellular TFEB concentration by
ectopic expression of GFP-TFEB, and quantified the
percentage of activated cells (mainly nuclear TFEB)
by fluorescence microscopy (Additional file 6: Figure S6).
The amount of activated cells was significantly increased
by GFP-TFEB expression compared to endogenous TFEB
levels. Furthermore, the effect of overexpression was par-
tially reversed by enhanced sequestration of TFEB in the
cytosol through overexpression of 14-3-3 isoform ɣ
(YWHAG), for which TFEB has a high binding affinity [6].
These results suggest that increased cellular TFEB protein
levels can trigger nuclear localization and override regula-
tion by mTOR, and that this effect is partially dependent
on 14-3-3 protein levels.
We identically applied our analysis framework to de-
fine TFEB subpopulations in the MCF7 cells time course
data (the workflow for defining cell line-specific subpop-
ulations is represented in Additional file 1: Figure S1).
Similar to HeLa cells, statistically-different clusters were
obtained, and the cluster with the highest nuclear
localization (“Active”) had the highest TFEB concentra-
tion, while the “Inactive” cluster displayed the lowest
TFEB levels (Fig. 4d, e).
(See figure on previous page.)
Fig. 4 Clustering-based analysis of subpopulation dynamics of TFEB activity in response to mTOR activity modulation by fresh FM and Torin1.
Subpopulation analysis of ISX multispectral imaging cytometry datasets from Fig. 3. a Schematic representation of the analysis workflow. Extracted
feature values from all treatments and time points were merged and analyzed using SPADE software for the identification of phenotypically similar
clusters. Clustering results were iteratively checked until finding a combination of features and number of clusters that yielded biologically sound and
reproducible results. Finally, evolution of subpopulations was observed by tracing the percentage of cells belonging to each cluster for each treatment
and time point. b Cluster phenotypes in HeLa cells. Bars represent the mean among all cells in each cluster ± SD (including FM, Torin1, and all
repetitions and time points). The number of cells equals 48774, 42994 and 23793 for cluster 1, 2 and 3, respectively. Statistical significances were tested
between clusters on 1000 randomly selected cells (two-sided Wilcoxon-rank-sum test; ***, p ≤ 0.001). c Cumulative frequency distribution for selected
features that were excluded during the generation of the clusters. Bars on the top right corners display the mean value among all cells in each
cluster ± SD. Statistical significances were tested between clusters on 1000 randomly selected cells (Student’s two-tailed t-test; ***, p ≤ 0.001). d
Clusters phenotype in MCF7 cells. Bars represent the mean among all cells in each cluster ± SD. Statistical significances were tested between
clusters on 1000 randomly selected cells (two-sided Wilcoxon-rank-sum test; ***, p ≤ 0.001). e Mean TFEB protein levels for the three clusters.
Bars represent the mean among all cells in each cluster ± SD. Statistical significances were tested between clusters on 1000 randomly selected
cells (Student’s two-tailed t-test; ***, p ≤ 0.001). f-g Subpopulation dynamics for the indicated treatments and cell lines. Reported values represent the
mean among three independent experiments ± SD. Regions shaded in grey highlight different stages in TFEB dynamic response. R1: short-term
rheostatic response, R2: long-term response
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Time course subpopulation responses to FM and Torin1
treatments
The temporal impact of fresh FM and Torin1 on the
population distribution among predicted activity states
was calculated for HeLa cells (Fig. 4f ). Results from
three independent experiments are shown in Additional
file 4: Figure S4. At time point 0, cells were equally dis-
tributed between the “Inactive” (45 %) and “Medium”
(46 %) subpopulations, while the fraction of “Active”
cells amounted to only 9 % (Fig. 4f ). Thus, under basal
metabolism TFEB activity is inactive-to-moderately ac-
tive for most cells. In response to fresh FM, at 0.5 hours
the “Inactive” subpopulation fraction increased from
45 % to nearly 100 % of the cell population, concurrent
with a decrease in the “Medium” subpopulation (from
46 to 6 %) and a depletion of the “Active” subpopulation
(region R1). Beginning at 1 hour, the “Inactive” subpopula-
tion decreased, concomitant with an increased “Medium”
subpopulation. At 15 hours a distribution of 21 %, 76 %
and 3 % for the “Inactive”, “Medium” and “Active” sub-
populations was reached, respectively (region R2). The de-
crease of the “Inactive” subpopulation is consistent with
the reduction in mTOR activity detected 5 and 15 hours
post FM treatment (Fig. 2c).
In contrast, Torin1 treatment induced a differential
subpopulation response, and did not drive 100 % of the
population towards a single activation state (Fig. 4f ).
Within 1.5 hours Torin1 reduced the “Inactive” subpop-
ulation to marginal levels (from 45 to 2 %), slightly re-
duced the “Medium” subpopulation (from 46 to 41 %),
and increased the “Active” subpopulation from 9 to 57 %
(region R1). Following 1.5 hours, the “Inactive” and
“Medium” subpopulations increased, concurrent to a de-
crease in “Active” subpopulation, and by 15 hours all
subpopulations were similarly re-distributed to time
point 0 levels, with 47 %, 45 % and 8 % of the cells in
the “Inactive”, “Medium” and “Active” subpopulations,
respectively (region R2).
Similar, but blunted, subpopulation redistributions were
observed in MCF7 cells (Fig. 4g). FM increased the per-
centage of cells in the “Inactive” subpopulation (from 57
to 67 %), concomitantly decreasing the “Medium” (from
33 to 26 %) and “Active” subpopulations (from 11 to 6 %),
while Torin1 decreased the “Inactive” fraction (to 14 %)
and increased the “Active” (to 42 %) and “Medium” sub-
populations (to 44 %). As observed in HeLa cells, TFEB
activation was gradually reversed starting 1.5 hours after
Torin1 treatment, nearly reaching the initial subpopula-
tion distribution after 15 hours (region R2). Notably, dif-
fering from HeLa cell results, FM treatment did not
inactivate 100 % of the population, suggesting that TFEB
activity is less sensitive to mTOR activation in MCF7 cells.
This is in accordance with the recently described lower
mTOR control over TFEB in pancreatic cancer cells [11].
Importantly, the mean population response of the
nuclear/cytoplasmic ratio could be accurately predicted
based on the subpopulation distributions (see Additional
file 7: Figure S7), confirming the consistency of our ana-
lysis at all time points.
Overall, the results from HeLa and MCF7 cells show
that subpopulation analysis reveals highly accurate cell
type-, condition-, and time-dependent phenotype dy-
namics. The above findings reveal that mTOR max-
imally induced cytoplasmic TFEB retention in all HeLa
cells, but fractionally in MCF7 cells. Conversely in both
cell types, Torin1 induced maximal TFEB nuclear con-
centration only in a fraction of cells, and following
1.5 hours of treatment, TFEB began a re-localization
to the cytoplasm, suggesting an early rheostat con-
trol by mTOR followed by TFEB re-inactivation
uncoupled from mTOR activity.
Time course quantification of TFEB mean population and
subpopulation responses to nutrient deprivation
We then investigated a physiological perturbation on
mTOR and TFEB, by subjecting HeLa cells to nutrient
deprivation [6, 7]. First, we calculated the mean popula-
tion responses for TFEB subcellular localization and
concentration (Fig. 5a). Nutrient deprivation transiently
increased the TFEB nuclear/cytoplasmic ratio (from
1.2 to maximally 1.7), peaking at 1 hour, subsequently
decreasing up to 5 hours (to 1.3), and then increasing
significantly again at 15 hours (to 1.6). Consistent
with the findings for Torin1, concomitant to inducing
nuclear translocation, nutrient deprivation induced a
significant increase in the cellular concentration of
TFEB, peaking at 1 hour with an increase of 41 %,
and then decreasing gradually. Of note, while nuclear
localization was increased again at 15 hours, TFEB
protein levels stayed low.
Next, we evaluated the TFEB subpopulation response
to nutrient deprivation. Cells were classified into “Ac-
tive”, “Medium” and “Inactive” phenotypes using the
classification model obtained above for FM and Torin1
treatments (see Additional file 1: Figure S1 for a sche-
matic of the classification workflow). Consistent with
FM and Torin1, the mean features obtained from the
nutrient deprivation data set showed that the “Active”
cluster, displayed the highest TFEB concentration, while
the “Inactive” cluster contained the lowest TFEB levels
(Fig. 5b).
Subsequently, we calculated the temporal impact of nu-
trient deprivation on the distribution of TFEB subpopula-
tions (Fig. 5c). Within 1 hour, nutrient deprivation induced
an initial activation wave (region R1), which reduced the
“Inactive” subpopulation (from 80 to 18 %) and increased
the “Medium” and “Active” subpopulations from 17 % and
3 % to 56 % and 25 %, respectively. Following 1 hour, TFEB
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was re-inactivated, moving 60 % of the cells to the
“Inactive” phenotype after 5 hours, and leading to full
loss of the “Active” subpopulation (region R2). Finally,
between 5 and 15 hours TFEB subpopulation dynamics
shifted again towards increasing “Medium” and “Active”
phenotypes (region R3).
Thus, similar to Torin1 treatment, nutrient deprivation
rapidly activated TFEB, increasing its nuclear localization.
However, in contrast to Torin1 treatment, the subsequent
reduction to TFEB nuclear localization was more rapid,
and then reversed.
Single cell correlation of TFEB activity states, LAMP1
concentration and lysosomal positioning in response to
nutrient deprivation
We subsequently sought to gain insight into functional
relevance of TFEB activity subpopulations during the re-
sponse to nutrient deprivation. Therefore, we simultan-
eously monitored responses of endogenous TFEB and
TFEB-controlled lysosomal marker LAMP1 [1, 2] by multi-
spectral imaging cytometry (Fig. 6a). Nutrient deprivation
significantly increased the cellular concentration of
LAMP1 for all time points up to 5 hours, peaking at
Fig. 5 Mean population and subpopulation response of TFEB to nutrient deprivation. HeLa cells were kept in culture medium (NT, non-treated)
or subjected to nutrient deprivation. At the indicated time points, cells were immunostained for TFEB and LAMP1, and Nuclei were labelled with
Hoechst 33342. Following, cells were analyzed by ISX multispectral imaging cytometry. a Time course of the mean population response of TFEB
subcellular localization and protein levels. Concentrations are shown relative to time point ‘0’. Reported values represent the mean among three
independent experiments ± SD. Unless specified by horizontal lines, statistical significance was tested vs. time point ‘0’, which corresponds to the
NT control (Student’s two-tailed t-test; *, p ≤ 0.05; **, p ≤ 0.01). b Mean TFEB subcellular localization and protein levels for the three activation
phenotypes in a cell population subjected to nutrient deprivation. Bars represent the mean among all cells in each cluster ± SD (from all repetitions and
time points). Statistical significance was tested between clusters on 1000 randomly selected cells (two-sided Wilcoxon-rank-sum test; ***, p ≤ 0.001).
c Dynamics of the distribution of cells among the three activation phenotypes in a cell population subjected to nutrient deprivation. Reported
values represent the mean among three independent experiments ± SD. Shaded regions highlight different stages in TFEB dynamic response.
R1: first activation wave, R2: re-inactivation, R3: second activation wave
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3 hours with an increase of 30 % and decreasing thereafter
(Fig. 6b). The delay in the peak in LAMP1 concentration
relative to TFEB is consistent with TFEB-mediated
lysosomal biogenesis. Notably, although at 15 hours
TFEB accumulated in the nucleus again (Fig. 5a, c),
no increase in TFEB (Fig. 5a) or LAMP1 (Fig. 6b)
levels was observed at this time point. Importantly,
LAMP1 concentration was significantly higher for the
“Active” cluster (~17 % increase relative to “Medium”
and “Inactive” clusters), demonstrating enhanced lysosomal
content and thus higher TFEB downstream signaling for
the phenotype classified as “Active” (Fig. 6c).
In addition, we analyzed the subcellular positioning
of lysosomes, which is intricately linked to the cellular
nutrient state [18]. To that end, we employed the
“LAMP1 Max Contour Position” feature, defined as the
location of the contour in the cell with the highest
LAMP1 intensity concentration [16]. As shown in
Fig. 6 Single cell correlation of nutrient deprivation-induced TFEB activity and downstream lysosomal response by multispectral imaging cytometry.
HeLa cells were kept in culture medium (NT, non-treated) or subjected to nutrient deprivation. At the indicated time points, cells were immunostained
for TFEB and LAMP1, and nuclei labelled with Hoechst 33342. Following, cells were analyzed by ISX multispectral imaging cytometry. a Bright field and
fluorescence images of representative cells for the indicated treatments. b Time course of the mean population response of LAMP1 protein levels,
shown relative to time point ‘0’. Reported values represent the mean among three independent experiments ± SD. Statistical significance was tested
vs. time point ‘0’, which corresponds to the NT control (Student’s two-tailed t-test; *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001). c Mean LAMP1 concentration
for the three TFEB activation phenotypes. Bars represent the mean among all cells in each cluster ± SD (from all repetitions and time points). Statistical
significance was tested between clusters on 1000 randomly selected cells (Student’s two-tailed t-test; ***, p ≤ 0.001; n.s. p > 0.05). d Representative
fluorescence images for different ranges of the feature “LAMP1 Max Contour Position” to assess lysosomal positioning. e Time course of the mean
population response of “LAMP1 Max Contour Position”, shown relative to time point ‘0’. Reported values represent the mean among three
independent experiments ± SD. Statistical significance was tested vs. time point ‘0’, which corresponds to the NT control (Student’s two-tailed t-test; *,
p ≤ 0.05; **, p ≤ 0.01). f Mean “LAMP1 Max Contour Position” for the three TFEB activation phenotypes. Bars represent the mean among all cells in each
cluster ± SD (from all repetitions and time points). Statistical significance was tested between clusters on 1000 randomly selected cells (two-sided
Wilcoxon-rank-sum test; ***, p ≤ 0.001). g Percentage of cells with values of “LAMP1 Max Contour Position” within the ranges specified in (d), presented
separately for each TFEB activation phenotype
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Fig. 6d and Additional file 8: Figure S8, values close to 0
indicate a centered (perinuclear) lysosomal distribution,
while values close to 1 indicate a peripheral (cytoplasmic)
lysosomal distribution. The mean population response
(Fig. 6e) demonstrates that within 0.5 hours, as expected
[18], nutrient deprivation significantly redistributed lyso-
somes to the nuclear region. This perinuclear lysosomal
distribution was maintained up to 5 hours, and after
15 hours lysosomes re-localized towards the cell periph-
ery. Notably, the three clusters displayed statistically dif-
ferent mean “LAMP1 Max Contour Position” values
(Fig. 6f) and clear differences between lysosomal position-
ing distributions (Fig. 6g), indicating that cells in the “In-
active” cluster contain the most peripheral lysosomes and
cells in the “Active” cluster contain the most perinuclear
lysosomes. Consistent with the inter-cluster differences,
“LAMP1 Max Contour Position” negatively correlated
with TFEB nuclear/cytoplasmic ratio in single cells, with a
correlation coefficient of −0.25 (see Additional file 1:
Figure S1, panel III). Overall, LAMP1 concentration dy-
namics and spatial distribution within subpopulations
indicate that the TFEB-defined subpopulations are of
physiological relevance for the cellular lysosomal state.
Maximal activation of TFEB under conditions of mTOR
inhibition is negatively regulated by the proteasome,
independently of TFEB concentration
ERK signaling does not impact TFEB activation in response
to Torin1 or nutrient deprivation
Finally, we sought to identify mechanisms which prohibit
maximal TFEB activation. We first explored a possible
contribution of ERK kinases, which were previously
shown to negatively regulate TFEB [4]. We treated HeLa
cells with the MEK1 and MEK2 inhibitor U0126 [4, 9]
alone or in co-treatment with Torin1 or nutrient dep-
rivation for 1.5 and 3 hours. We found that U0126 did not
significantly impact Torin1- or nutrient deprivation-
induced increases in the fraction of “Active” cells (Fig. 7a),
nor in mean TFEB concentrations (Fig. 7b). Of note, treat-
ment with fresh FM containing U0126 (Fig. 7a) led to a
lesser deactivation of TFEB than treatment with fresh FM
alone (Fig. 4f). Together, these results indicate that ERK
signalling does not restrain the early phase of TFEB acti-
vation under the conditions tested here.
Maximal TFEB activation by Torin1 is negatively regulated
by the proteasome
As increased TFEB activation correlated with increased
TFEB protein levels (see Additional file 1: Figure S1,
panel II), we next sought to determine whether the ini-
tial changes in TFEB protein levels could be attributed
to proteasomal degradation or protein synthesis. There-
fore, we treated HeLa cells with the proteasome inhibi-
tor epoxomicin (1 μM) or the transcriptional inhibitor
actinomycin D (1 μg/mL), alone or in combination with
Torin1 for 1 hour (Fig. 7c). Neither epoxomicin nor acti-
nomycin D had a significant effect on TFEB levels for all
tested conditions, indicating that, within the period of
rapid TFEB concentration changes, proteasomal degrad-
ation and transcriptional regulation do not play a signifi-
cant role. We thus speculate that TFEB changes might
be regulated via lysosomal degradation. However, as im-
pairment of lysosomal function activates TFEB [9], an
unbiased assessment of the involvement of lysosomal
degradation on TFEB levels is not readily possible and
requires future investigation.
Of note, while epoxomicin had no impact on the
nuclear/cytoplasmic ratio under control conditions, nu-
clear TFEB localization was significantly increased under
epoxomicin and Torin1 co-treatment (Fig. 7d). Subpopu-
lation analysis demonstrates that this effect was due to a
significant increase in the subpopulation with “Active”
TFEB (to 96 %) (Fig. 7d), and was not related to changes
in total TFEB levels (Fig. 7e).
Discussion
Here we investigated the relationship between modula-
tions to mTOR activity and the consequent changes to
localization and concentration of TFEB in HeLa and
MCF7 cells. We report the novel findings that mTOR
exerts a rapid, time-limited rheostat control on TFEB
subcellular localization and protein levels (see Fig. 8).
During the period of 0.5 to 1.5 hours following perturb-
ation, mTOR activation decreased TFEB protein levels
and increased TFEB cytoplasmic retention. Conversely,
in response to mTOR inhibition by either Torin1 or nu-
trient deprivation, during this period, TFEB protein
levels rapidly increased concurrent to enhanced accumu-
lation of TFEB in the nucleus. Surprisingly, this effect
was limited in duration to a period of 3 hours, and dur-
ing the period of 3 to 15 hours, TFEB concentrations
and subcellular distributions returned towards basal
levels for all conditions, evidencing homeostatic regula-
tory mechanisms dependent and independent of mTOR.
While we show that mTOR activation maximally in-
hibits TFEB, mTOR inhibition only fractionally activated
TFEB. Furthermore, our findings indicate that ERK sig-
naling exerts a negligible inhibitory effect on TFEB
under nutrient deprivation and Torin1 conditions, and
instead indicate a role for proteasome degradation path-
ways in the regulation of TFEB subcellular localization
(see Fig. 8) independent of TFEB levels.
Subpopulation analysis reveals accurate TFEB signaling
behavior
We achieved highly accurate analysis of spatial and
temporal TFEB dynamics by subpopulation analysis.
To decompose cellular heterogeneity into discrete
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Fig. 7 Effect of ERK, proteasome and transcriptional inhibition on mTOR inhibition-mediated TFEB activation. a HeLa cells were treated with fresh
FM supplemented with U0126 (10 μM) alone or in co-treatment with Torin1 (2 μM), or subjected to nutrient deprivation (ND) alone or in combination
with U0126. Following immunostaining for TFEB and labeling of nuclei with Hoechst 33342 cells were analyzed by multispectral imaging cytometry.
For visualization, the data for FM supplemented with U0126 is included both for Torin1 (left) and for ND (right) treatments. Bars report
mean subpopulation distributions among three independent experiments ± SD. Statistical significance was tested based on the “Active” subpopulation
vs. non-treated control (NT), unless otherwise indicated by horizontal lines (Student’s two-tailed t-test; *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; n.s.,
p > 0.05). b Mean population response of TFEB concentration in HeLa cells treated as in (a), shown relative to the non-treated levels (NT).
Unless indicated by horizontal lines, statistical significance was tested vs. non-treated control, NT (Student’s two-tailed t-test; *, p ≤ 0.05; **,
p ≤ 0.01; ***, p ≤ 0.001; n.s., p > 0.05). c Mean population response of TFEB concentration (relative to the non-treated levels, NT) in HeLa cells
treated with Epox (1 μM), ActD (1 μg/mL) or vehicle control (DMSO) alone or in combination with Torin1 (2 μM). Bars report the mean among
four independent experiments ± SD. Statistical significances were tested with Student’s two-tailed t-test (*, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; n.s.,
non-significant). d Mean population response of TFEB subcellular localization and subpopulation distributions for HeLa cells treated as in (c). Bars report
the mean among four independent experiments ± SD. Statistical significances were tested with Student’s two-tailed t-test (**, p ≤ 0.01; ***, p ≤ 0.001;
n.s., non-significant). Subpopulations were compared based on the “Active” phenotype. e Mean TFEB concentration for the three activation phenotypes
in a subset of cells treated with Torin1 alone or in co-treatment with epoxomicin, as indicated in (c). Bars represent the mean among all cells in each
cluster for the indicated treatments ± SD
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subpopulations of TFEB activation states we used ag-
glomerative clustering [19–21] of single-cell imaging
datasets, and established criteria to optimize the number
of phenotypes and input features. We identified “Active”,
“Medium” and “Inactive” TFEB subpopulations which
significantly and reproducibly correlated with TFEB
signaling. Consistent with TFEB activation of lysosomal
biogenesis [4], the “Active” subpopulation reported higher
lysosomal content than “Medium” and “Inactive” subpop-
ulations (Fig. 6c). Moreover, “Active”, “Medium” and “In-
active” subpopulations reported significant differences in
lysosomal positioning (Fig. 6f, g), an indicator of the cellu-
lar metabolic state. In response to nutrient deprivation,
the “Active” subpopulation was enriched with perinuclear
lysosomes, which report a starvation response, while the
“Inactive” was enriched with mixed and peripheral lyso-
somes, which indicate normal growth conditions [18]. We
therefore conclude that subpopulation analysis of TFEB
distribution and concentration reveals the time course
response of TFEB to metabolic stress.
mTOR activity modulations induce distinct time-evolving
TFEB subpopulation redistributions
Quantifying TFEB subpopulation redistributions over
time, we found that with the addition of fresh FM, which
mildly increased mTOR activity (Fig. 1d), TFEB hetero-
geneity was rapidly lost in HeLa cells (Fig. 4f). In contrast,
consistent but smaller population shifts were measured in
MCF7 cells (Fig. 4g), suggesting a cell line-dependent
lower sensitivity to mTOR activation, possibly related to
altered nuclear import of TFEB [11]. Notably, subpopula-
tion analysis revealed that at 15 hours post FM treatment,
a small percentage of HeLa cells switched to the less
active “Medium” phenotype. This subpopulation shift may
reflect the consumption of nutrients and/or growth fac-
tors, as indicated by decreased 4E-BP1 phosphorylation
(Fig. 2c).
In contrast to FM, in both HeLa and MCF7 cells,
Torin1 rapidly depleted the “Inactive” subpopulation
and increased “Active” and “Medium” subpopulations
(Fig. 4f, g). Strikingly, while Torin1 inhibition of mTOR
was maintained for 15 hours (Fig. 2f ), TFEB re-inactiva-
tion began 1.5 hours following Torin1 treatment and re-
quired 15 hours to inactive approximately 50 % of the
population, compared to 100 % inactivation by fresh FM
at 0.5 hours. These findings evidence an additional
mTOR-independent, negative regulatory mechanism, en-
gaged similarly in HeLa and MCF7 cells under conditions
of prolonged mTOR inhibition. Putative mechanisms may
involve phosphorylation by GSK3 [12], multiple serine
phosphorylations [4, 22], and/or other post-translational
modifications such as SUMOylation [23].
Notably, nutrient deprivation-mediated activation of
TFEB differed from Torin1 treatment. While Torin1
strongly induced the “Active” subpopulation and depleted
the “Inactive” subpopulation (Fig. 4f), nutrient deprivation
mostly increased the “Medium” subpopulation without
depleting the “Inactive” subpopulation (Fig. 5c). Further,
distinct from Torin1 treatment, between 1.5 and 5 hours
(R2 period) TFEB was rapidly inactivated, and between 5
and 15 hours (R3 period) both “Active” and “Medium”
subpopulations increased, suggesting a second activation
wave.
We suggest this alternating behavior was due to nega-
tive feedback of autophagy on mTOR, as we previously
predicted by agent-based modeling [24]. Here we report
that lysosomal content and perinuclear clustering were
maximal during the first 5 hours of nutrient deprivation
(Fig. 6b, e), indicative of maximal autophagy activation,
Fig. 8 Proposed dynamic regulatory network of TFEB. TFEB is under
long-term (dark blue area) and short-term (light blue area) control,
regulating the strength and time span of its activation, i.e., nuclear
localization. The long-term control limits the duration of TFEB
activation upon sustained mTOR inhibition, displaying prominent
mTOR-independent negative regulation of TFEB. The short-term
control acts as a rheostat, which is highly sensitive to inactivation
by mTOR, but tightly controls TFEB activation by multiple mechanisms,
directly or indirectly regulated by mTOR. Under conditions of
sustained mTOR inhibition (Fig. 2d, f), starting at 3 hours, TFEB is
gradually inactivated (Fig. 4f, region R2), evidencing the action of
other inhibitors with slower kinetics than mTOR. In contrast to
Torin1 mTOR inhibition, nutrient deprivation displays a fast reactivation
kinetics (Fig. 5c, region R2) followed by a second activation wave
(Fig. 5c, region R3), suggesting that TFEB rheostat is sensitive to
autophagy feedback on mTOR activity via nutrient recycling.
Proteasome inhibition by epoxomicin enhances TFEB activation
(Fig. 7d), suggesting that the proteasome mediates the degradation of
a “positive regulator” of TFEB, labeled here with a question mark.
The effect of epoxomicin on TFEB activation is only detectable under
conditions of mTOR inhibition (Fig. 7d), suggesting that the “positive
regulator” is not degraded under conditions of high mTOR activity
(i.e., mTOR activity inhibits the degradation of the “positive regulator”)
Marin Zapata et al. BMC Cancer  (2016) 16:355 Page 16 of 19
which could provide recycled nutrients sufficient to re-
activate mTOR and thereby inactivate TFEB. Subse-
quently, after 5 hours, depletion of autophagy recycled
nutrients could lead to renewed inactivation of mTOR,
which is in agreement with the observed re-activation
of TFEB at 15 hours of nutrient deprivation. Interestingly,
at this time point TFEB nuclear localization is not paral-
leled with increases in either TFEB or LAMP1 protein
levels. Moreover, also at 15 hours, lysosomes localized at
the cell periphery (Fig. 6e). These observations might be
due to depletion of intracellular substrates following
prolonged nutrient deprivation. Future studies will explore
whether peripheral lysosomal redistribution reflects a cel-
lular shift toward exploiting endocytic nutrient sources.
During pharmacological mTOR inhibition the proteasome
negatively regulates nuclear localization of TFEB
Notably, we show that under Torin1 treatment and
during early phases of nutrient deprivation TFEB protein
levels correlate with subcellular localization. This is con-
sistent with increased transcription of autophagy and
lysosomal genes following TFEB overexpression [1, 2, 6].
Using specific inhibitors, we ruled out that initial (within
1 hour) increases and decreases in TFEB levels were due
to protein translation or proteasomal activities (Fig. 7c),
indicating that transcriptional feedback [25] is not rele-
vant during the first hour of treatment. These results
further suggest that TFEB may be targeted for lysosomal
degradation, thereby forming a negative feedback circuit.
However, lysosomal stress potently activates TFEB [9]
and therefore putative lysosomal targeting of TFEB re-
quires further investigation.
Importantly, we found that mTOR inactivation failed to
maximally activate TFEB in all cells of a cell population
(Fig. 4f, g). Our findings exclude ERK signaling as a limiting
factor (Fig. 7a). Instead, we identified a novel TFEB inhibi-
tory role for the proteasome, under conditions of mTOR in-
hibition. Selectively in Torin1-treated cells, epoxomicin-
mediated inhibition of the proteasome leads to “Active” nu-
clear localization of TFEB in nearly 100 % of cells (Fig. 7d),
without altering TFEB protein levels (Fig. 7c, e). The mech-
anism by which the proteasome negatively regulates TFEB
remains to be determined. We propose an indirect pathway,
in which mTOR activity inhibits proteasomal degradation of
a positive TFEB regulator. Thereby, maximal activation of
TFEB nuclear translocation requires inhibition of mTOR
and proteasome activities (see Fig. 8). Alternatively, prote-
asome inhibition might activate TFEB via induction of pro-
teotoxic stress [26], which might be exacerbated under
conditions of decreased mTOR activity [27].
Conclusions
Overall, we demonstrate that TFEB levels and subcellular
distribution undergo distinct short-term and long-term
control. Our findings suggest that the rapid rheostatic re-
sponse, mediated by mTOR, allows the cell to quickly
adapt to metabolic changes, while the long-term, mTOR-
independent homeostatic response controls the magni-
tude and duration of TFEB activation, and presumably
limits excessive autophagy. Our findings also suggest that
TFEB may be targeted by lysosomes, and that under con-
ditions of mTOR inhibition the proteasome regulates the
early response of TFEB localization, uncoupled from
changes to TFEB levels. As TFEB is a central player in
cancer [11, 12], our approach to time series analyses of
magnitude and dynamics of subpopulation shifts enables
biomarker assessment of cell line sensitivity and respon-
siveness. We propose our approach as a useful general
framework for identifying and quantifying information
contained within heterogeneous imaging datasets.
Additional files
Additional file 1: Figure S1. Work flow for classification of cell
subpopulations. Initially, cells subjected to FM or Torin1 treatments are
classified into three groups/clusters (denoted as activation phenotypes)
using agglomerative clustering on the base-clustering-feature “Mean
Pixel Nuc/Cyto” (See Fig. 4a). The resulting classification criteria, consisting of
thresholds on the base-clustering-feature, constitute our data-based model
for cell classification. This model is estimated separately for HeLa and MCF7
cells, and thus, is cell line specific. The activation phenotypes are further
characterized by identifying additional phenotypic differences between the
cell groups. To this end, the three clusters are statistically compared based
on a set of features which were not used in the generation of the cell
classification model. Besides identifying features which are specific to
each activation phenotype, significant differences between the cell groups
report correlations between the evaluated features and the base clustering
feature (exemplified by the correlation coefficients and correlation plots on
the top right corners of the grey panels). Finally, the FM and Torin1
data-based model is used as a basis for cell classification in response to
other treatments such as nutrient deprivation, and inhibition of ERK,
proteasome or protein translation (model extrapolation). (JPG 7051 kb)
Additional file 2: Figure S2. Comparison of imaging cytometry (ISX)
and wild-field microscopy (WF) approaches to measure endogenous TFEB
subcellular distribution. Representative WF and ISX immunofluorescence
images of endogenous TFEB in HeLa cells treated with fresh full medium
(FM, 0.5 hours), Torin1 (1 hour) or left untreated (NT). Graphs represent
normalized intensity profiles for Hoechst (purple) and TFEB (orange)
along the indicated red line. Both measurement approaches show similar
intensity profiles for each experimental condition. (JPG 2766 kb)
Additional file 3: Figure S3. Representative imaging cytometry images
of endogenous TFEB under different treatments with indicated nuclear
and cellular contours. (a) Non- treated: Most cells display slightly higher
cytosolic concentration, and some cells display similar concentrations in
nuclear and cytosolic compartments. (b) Fresh full medium: Cells display
higher cytosolic than nuclear concentration. (c) Torin1: Cells display
higher nuclear than cytosolic concentration. (JPG 4456 kb)
Additional file 4: Figure S4. Positive clustering example. To demonstrate
the reproducibility of the clustering outcome, we separately present the
curves from three independent experiments (rows 1 to 3) and the combined
mean response ± SEM (row 4), which corresponds to the subpopulation
dynamics presented in Fig. 4f. The result was obtained using three clusters
and the feature “Mean Pixel Nuc/Cyto” as input. Importantly, treatments with
FM and Torin1 induced a clear redistribution of the cell population among the
different phenotypes (clusters). This distribution was consistent among the
three repetitions and displayed independent dynamics for each cluster, thus
adhering to our first and second evaluation criteria, respectively. (JPG 1499 kb)
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Additional file 5: Figure S5. Negative clustering examples. (a) Example
of a clustering outcome dissatisfying criterion 1, i.e., reproducibility of the
dynamic distribution of cells among clusters. The result was obtained using
three clusters with the following input features: area cell, concentration cell,
and “Mean Pixel Nuc/Cyto”. In this case, the evolution in time of the
percentage of cells in clusters 1 (blue) and 2 (black) is not reproducible. (b)
Example of a clustering outcome dissatisfying criterion 2, i.e., non-redundant
dynamics. The result was obtained using four clusters with the input feature
“Mean Pixel Nuc/Cyto”. In this case, clusters 1 (black) and 3 (blue) follow
similar dynamic responses to all treatments, indicating that the two clusters
are redundant. (JPG 2839 kb)
Additional file 6: Figure S6. Nuclear localization of TFEB is influenced
by total levels of cellular TFEB. (a) HeLa cells were subjected or not to
transfections with the indicated constructs and treated 24 hours post
transfection with 2 μM Torin1 for 3 hours or left non-treated (NT).
Representative images demonstrate the subcellular distribution of
TFEB fluorescence for endogenous TFEB (TFEB immunofluorescence, IF), or
transiently overexpressed GFP-TFEB, expressed alone or coexpressed with
RFP-tagged 14-3-3 protein isoform YWHAG. The look-up-table ‘Fire’ (ImageJ)
was applied to grey scale images of TFEB or GFP-TFEB fluorescence,
representing ranging from high (white) to low (dark purple) intensity
values, as displayed in color scale bar. Scale bars (white line), 20 μm. (b)
Quantification of the number of cells with mainly nuclear TFEB fluorescence.
At least 30 cells were scored per condition and experiment in three
independent experiments. Statistical significance was tested using
two-tailed Student’s t-test (**, p ≤ 0.01; ***, p ≤ 0.001). (JPG 1702 kb)
Additional file 7: Figure S7. Mean population response of nuclear/
cytoplasmic ratio predicted from subpopulation distributions. Dots and error
bars: mean population response ± SD found experimentally, as presented in
Fig. 3b, d. Dotted lines: mean population response predicted based on
subpopulation distributions. The predicted mean population response (F)
was estimated as follows F = ( αIFI + αMFM + αAFA )/100, where FI, FM and
FA are the mean “Mean Pixel Nuc/Cyto” of the “Inactive”, “Medium” and
“Active” clusters, respectively, and αI, αM and αA are the percentage of cells
in each cluster. FI, FM and FA are constants (presented in Fig. 4b, d), while
and αI, αM and αA are functions of time given by the curves in Fig. 4f, g.
(JPG 657 kb)
Additional file 8: Figure S8. Extended representative data set of
lysosomal positioning. (a) Schematic representation of the feature “MAX
Contour Position” used to quantify lysosomal positioning. (b) Representative
LAMP1 immunofluorescence images for different ranges of the feature
“LAMP1 MAX Contour Position” in HeLa cells treated as in Fig. 6. (JPG 3911 kb)
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